Article
Preventing metastatic recurrence in low-risk ER/PR+ breast cancer patients – a retrospective clinical study exploring the evolving challenge of persistence with adjuvant endocrine therapy
2022-10-11
Abstract excerpt
<title>Abstract</title> <p><bold>Purpose:</bold> In the genomic era, more women with low-risk breast cancer will forego chemotherapy and rely on adjuvant endocrine therapy (AET) to prevent metastatic recurrence. However, some of these patients will unfortunately relapse. We sought to understand this outcome. Preliminary work suggested that early discontinuation of AET, also known as non-persistence, may play an i...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8a196d61-84f8-5ef1-ada9-3c813d5822ac
- DOI
- 10.21203/rs.3.rs-2085411/v1
